A novel TM4SF4-targeting therapeutic antibody candidate with antitumor activity by blocking IGF1R and CD44 signaling and downregulating PD-L1 and B7-H4. [PDF]
TheranosticsKim RK +14 more
europepmc +1 more source
B7-H3 (CD276) regulates myeloid-derived suppressor cell differentiation in pulmonary fibrosis. [PDF]
Front ImmunolGonzalez De Los Santos F +5 more
europepmc +1 more source
Regulation and Mechanism of Deleted in Breast Cancer-1 on Dendritic Cell Function in Systemic Lupus Erythematosus. [PDF]
MedComm (2020)Xiao ZX +9 more
europepmc +1 more source
From M7824 to SHR-1701: lessons for dual PD-L1/TGF-β targeting. [PDF]
J Immunother CancerYi M, Li T, Wu K, Dai Z.
europepmc +1 more source
Beyond local control: radiotherapy-immunotherapy combinations from <i>in situ</i> vaccination to systemic immune remodeling. [PDF]
Front GenetWen Y, Cheng N, Zhou S, Zhu H, Ge Q.
europepmc +1 more source
Targeting Immune Checkpoint Proteins in Cancer Therapy and the Potential of RNAi-Based Immunotherapy. [PDF]
Pharmaceuticals (Basel)Wang KK, Yu AM.
europepmc +1 more source
Deletion of Lymphatic PD-L1 Protects Mice From Severe Autoimmune Encephalitis. [PDF]
Eur J ImmunolWang Z +8 more
europepmc +1 more source
Enhanced renal ischemia/reperfusion injury repair potential of exosomes derived from B7-H1<sup>high</sup> mesenchymal stem cells. [PDF]
Front GenetHe J +9 more
europepmc +1 more source
Natural Killer (NK) Cells in Tumor Immunity: Limitations and Therapeutic Potential with a Focus on Nasopharyngeal Carcinoma and Comparison with T-Cell-Based Therapies. [PDF]
CellsMakowska A, Kontny U.
europepmc +1 more source
TNFAIP3 Reprograms T Cell Exhaustion and Restores Anti-Leukemia Immunity in Acute Myeloid Leukemia. [PDF]
Cancer Manag ResLi Y +7 more
europepmc +1 more source